News from theravida, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 02, 2013, 08:00 ET

TheraVida and SK Chemicals Announce License Agreement for the Development and Commercialization of THVD-201 and THVD-202 for Overactive Bladder in South Korea

 TheraVida, Inc. and SK Chemicals Co., Ltd. (KRX: 006120) announced today the execution of a license agreement for two of TheraVida's...

Mar 18, 2013, 13:15 ET

TheraVida Presents Positive Phase 2 Data for Tolenix™ (THVD-201) in Patients with Overactive Bladder at the 28th Annual Congress of the European Urological Association

TheraVida, Inc., a clinical-stage biopharmaceutical company developing novel combination drug products, presented positive results from a Phase 2...

Jan 03, 2013, 08:30 ET

TheraVida Announces Positive Top-Line Phase 2 Results for Tolenix™ (THVD-201) in Patients with Overactive Bladder and Urge Urinary Incontinence

TheraVida, Inc., a clinical-stage biopharmaceutical company developing novel combination drug products, announced positive results from a Phase 2...

Oct 17, 2012, 07:07 ET

TheraVida Presents Positive Proof-of-Concept Results at the 2012 International Continence Society (ICS) Annual Meeting

TheraVida, Inc., a clinical stage biopharmaceutical company developing novel combination drug products, announced positive results from two small...

May 13, 2011, 15:24 ET

TheraVida Initiates Phase 2 Trial of THVD-201 for Overactive Bladder and Urinary Incontinence

MOUNTAIN VIEW, Calif., and SYDNEY, May 16, 2011 /PRNewswire-iReach/ -- TheraVida, Inc., a clinical stage biopharmaceutical company developing novel...

Mar 22, 2011, 19:35 ET

TheraVida Announces Positive Results From a Phase 1 Trial of THVD-201 for Overactive Bladder at the 2011 Annual Congress of the European Association of Urology

TheraVida, Inc., a clinical stage biopharmaceutical company developing novel combination drug products, today presented positive results from a...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge